Dr Emma Lidington, PhD

Profile

I joined the Cancer Prevention Trials Unit (previously at King’s College London) in February 2022 as a post-doctoral research associate in behavioural science. My background is in psychobiology and public health research. I did my PhD on the care experiences and supportive care needs of young adults with cancer. I also conducted similar work focusing on the development and use of patient-reported outcomes in cancer research and routine care and is currently the Publications Editor of the EORTC Quality of Life Group.

I moved from the Royal Marsden NHS Foundation Trust where I was a trial manager in a new team implementing a system for digitally collecting patient-reported outcomes in clinical trials.

My research now focuses on using behavioural science to understand and encourage participation in cancer prevention clinical trials and the acceptability and psychological impact of new cancer screening programmes. 

Research

Research Interests:

•    Understanding the psychological impact and acceptability of new screening tests and programmes, for example in relation to a new at-home urine testing kit for bladder cancer and the new capsule sponge test for oesophageal cancer
•    Understanding barriers and facilitators to uptake of new screening tests and programmes
•    Exploring the use of patient-reported outcomes to assess relevant psychological concepts
•    Understanding and improving the inclusivity of population-based cancer screening trials

Publications

• Rothmund M, Pilz MJ, Egeter N et al. . Comparing the contents of patient-reported outcome measures for fatigue: EORTC CAT Core, EORTC QLQ-C30, EORTC QLQ-FA12, FACIT, PRO-CTCAE, PROMIS, Brief Fatigue Inventory, Multidimensional Fatigue Inventory, and Piper Fatigue Scale.

  
  

  DOI: 10.1186/s12955-024-02316-0

  
  

  QMRO:
• Vrancken Peeters NJMC, Husson O, Kulakowski R et al. (2024). Evaluating a digital tool for supporting people affected by breast cancer: a prospective randomized controlled trial—the ADAPT study.

  
  

  DOI: 10.1007/s00520-024-08923-3

  
  

  QMRO:
• Peeters NJMCV, Georgopoulou S, Kulakowski R et al. (2024). Patient activation of breast cancer patients: results from the longitudinal ADAPT Study.

  
  

  DOI: 10.1080/28352610.2024.2409286

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/101247
• van der Weijst L, Machingura A, Alanya A et al. (2024). Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs.

  
  

  DOI: 10.1016/j.ejca.2024.114313

  
  

  QMRO:
• Peeters NV, Husson O, Kulakowski R et al. (2024). 272P Evaluating a digital tool for supporting people affected by breast cancer: A prospective randomised controlled trial - The ADAPT study.

  
  

  DOI: 10.1016/j.esmoop.2024.103330

  
  

  QMRO:
• Pilz MJ, Rothmund M, Lidington E et al. (2023). Content comparison of the EORTC CAT Core, SF‐36, FACT‐G, and PROMIS role and social functioning measures based on the International Classification of Functioning, Disability and Health.

  
  

  DOI: 10.1002/pon.6188

  
  

  QMRO:
• Schut AW, de Bruin LE, de Rooij BH et al. (2023). Physical symptom burden in patients with desmoid‐type fibromatosis and its impact on health‐related quality of life and healthcare use.

  
  

  DOI: 10.1002/cam4.5985

  
  

  QMRO:
• Rothmund M, Pilz MJ, Egeter N et al. (2023). Patient‐reported outcome measures for emotional functioning in cancer patients: Content comparison of the EORTC CAT Core, FACT‐G, HADS, SF‐36, PRO‐CTCAE, and PROMIS instruments.

  
  

  DOI: 10.1002/pon.6109

  
  

  QMRO:
• Schut A-R, Lidington E, Timbergen M et al. (2023). Unraveling Desmoid-Type Fibromatosis-specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes.

  
  

  DOI: 10.1016/j.ejso.2022.11.192

  
  

  QMRO:
• Schurr T, Loth F, Lidington E et al. . Patient-reported outcome measures for physical function in cancer patients: content comparison of the EORTC CAT Core, EORTC QLQ-C30, SF-36, FACT-G, and PROMIS measures using the International Classification of Functioning, Disability and Health.

  
  

  DOI: 10.1186/s12874-022-01826-z

  
  

  QMRO: